We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Fycompa

News List

Eisai seeks EMA approval for Fycompa to treat epilepsy in paediatrics pharmaceutical-technology
February 15, 2019
Eisai has submitted an application to the European Medicines Agency (EMA) seeking approval for the use of its Fycompa (perampanel) medicine to treat paediatric patients suffering with epilepsy....
Eisai to present latest data on Perampanel at AES annual meeting biospectrumasia
November 23, 2018
It is available in tablet form to be taken once daily, and a new oral suspension formulation has been approved and is being marketed in the United States
Eisai Pharma to cater to the Japanese market expressbpd
August 23, 2017
Launches new anti-epileptic drug Fycompa (perampanel) in India